Teva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOOXNGN3pjSGNMdGluU1gwMzRlYkdqNW14dVFIRkhBLUFudWxKdk85SUxnaWk4SGVQUDFTbFZlS2FhQTVJeXJvMjFTR25XcmpKVEM1SHlUZlY0czJsMDJGS1N1aFdzTk5wZldTWFkyVVhqdE5KZjdjQkpBd0RScmRiajlDRGtZSmNVUEQwbFNXbGFqaXplNjRjMjhqTnFSOGtWeWsxVE42T3J0ZVkwaFZKX2QwVFI3MEk?oc=5" target="_blank">Teva wins FDA approval for monthly schizophrenia injection Weltruza</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMMexico says FDA lettuce probe did not conclusively identify contamination source - Reuters
Mexico says FDA lettuce probe did not conclusively identify contamination source Reuters
October 3, 2026 at 11:43 PMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AM